Details of the Drug

General Information of Drug (ID: DMTRTGZ)

Drug Name

Pegylated carboxyhemoglobin

Indication

Disease Entry	ICD 11	Status	REF
Sickle-cell disorder	3A51	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01925001) Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis. U.S. National Institutes of Health.